Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
122 EUR | -0.77% | +2.31% | +54.69% |
Apr. 11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
Apr. 11 | UCB : Berenberg, Buy, raises its price target | CF |
Sales 2024 * | 5.62B 6.06B | Sales 2025 * | 6.33B 6.82B | Capitalization | 23.16B 24.99B |
---|---|---|---|---|---|
Net income 2024 * | 407M 439M | Net income 2025 * | 852M 919M | EV / Sales 2024 * | 4.42 x |
Net Debt 2024 * | 1.64B 1.77B | Net Debt 2025 * | 816M 880M | EV / Sales 2025 * | 3.79 x |
P/E ratio 2024 * |
58.5
x | P/E ratio 2025 * |
26.9
x | Employees | 8,767 |
Yield 2024 * |
1.15% | Yield 2025 * |
1.18% | Free-Float | 61.44% |
Latest transcript on UCB
1 day | -0.77% | ||
1 week | +2.31% | ||
Current month | -2.01% | ||
1 month | +1.16% | ||
3 months | +30.84% | ||
6 months | +84.64% | ||
Current year | +54.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 11-05-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 57 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 63 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-04-27 | |
Dame Davies
BRD | Director/Board Member | 73 | 13-12-31 |
Chief Executive Officer | 65 | 11-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 2 M€ | +11.01% | ||
0.72% | 14 M€ | +5.66% | - | |
0.72% | 5 M€ | +10.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 122 | -0.77% | 175,022 |
24-05-10 | 123 | +3.58% | 215,199 |
24-05-09 | 118.8 | -2.06% | 243,924 |
24-05-08 | 121.2 | +1.13% | 189,995 |
24-05-07 | 119.9 | +0.50% | 372,920 |
Real-time Euronext Bruxelles, May 13, 2024 at 11:37 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.69% | 25.14B | |
-1.95% | 89.08B | |
+2.76% | 40.9B | |
-12.92% | 32.25B | |
-16.51% | 15.39B | |
-8.27% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B | |
-7.60% | 8.62B |
- Stock Market
- Equities
- UCB Stock